Read More 1 minute read Analyst Ratings News Price Target Upgrades William Blair Upgrades Under Armour to Buy, Announces $11 Price Target By Benzinga Newsdesk March 16, 8:57 AM William Blair analyst Sam Poser upgrades Under Armour (NYSE:UAA) from Hold to Buy and announces $11 price target. UAA
Read More 1 minute read Analyst Ratings News Price Target Upgrades DA Davidson Upgrades Alamo Group to Buy, Raises Price Target to $196 By Benzinga Newsdesk March 16, 8:24 AM DA Davidson analyst Michael Shlisky upgrades Alamo Group (NYSE:ALG) from Neutral to Buy and raises the price target from $173 to $196. ALG
Read More 1 minute read Analyst Ratings News Price Target Upgrades Guggenheim Upgrades TPI Composites to Buy, Announces $22 Price Target By Benzinga Newsdesk March 16, 6:58 AM Guggenheim analyst Joseph Osha upgrades TPI Composites (NASDAQ:TPIC) from Neutral to Buy and announces $22 price target. TPIC
Read More 1 minute read Analyst Ratings News Price Target Upgrades Susquehanna Upgrades Skyworks Solutions to Positive, Announces $135 Price Target By Benzinga Newsdesk March 16, 6:56 AM Susquehanna analyst Christopher Rolland upgrades Skyworks Solutions (NASDAQ:SWKS) from Neutral to Positive and announces $135 price target. SWKS
Read More 1 minute read Analyst Ratings News Price Target Upgrades Baird Upgrades Choice Hotels Intl to Outperform, Raises Price Target to $134 By Benzinga Newsdesk March 16, 5:48 AM Baird analyst Michael Bellisario upgrades Choice Hotels Intl (NYSE:CHH) from Neutral to Outperform and raises the price target from $133 to $134. CHH
Read More 1 minute read Analyst Ratings News Price Target Upgrades Wells Fargo Upgrades HF Sinclair to Overweight, Announces $55 Price Target By Benzinga Newsdesk March 16, 5:46 AM Wells Fargo analyst Roger Read upgrades HF Sinclair (NYSE:DINO) from Equal-Weight to Overweight and announces $55 price target. DINO
Read More 1 minute read Analyst Ratings News Price Target Upgrades JP Morgan Upgrades Mersana Therapeutics to Overweight, Announces $10 Price Target By Benzinga Newsdesk March 16, 5:36 AM JP Morgan analyst Brian Cheng upgrades Mersana Therapeutics (NASDAQ:MRSN) from Neutral to Overweight and announces $10 price target. MRSN
Read More 1 minute read Analyst Ratings News Price Target Upgrades Telsey Advisory Group Upgrades Foot Locker to Outperform, Raises Price Target to $50 By Benzinga Newsdesk March 16, 5:15 AM Telsey Advisory Group analyst Joseph Feldman upgrades Foot Locker (NYSE:FL) from Market Perform to Outperform and raises the price target from $39 to $50. FL
Read More 1 minute read Analyst Ratings News Price Target Upgrades Oppenheimer Upgrades ORIC Pharmaceuticals to Outperform, Announces $14 Price Target By Benzinga Newsdesk March 16, 4:51 AM Oppenheimer analyst Matthew Biegler upgrades ORIC Pharmaceuticals (NASDAQ:ORIC) from Perform to Outperform and announces $14 price target. ORIC
Read More 1 minute read Analyst Ratings News Price Target Upgrades Stifel Upgrades FedEx to Buy, Raises Price Target to $222 By Benzinga Newsdesk March 16, 4:50 AM Stifel analyst J. Bruce Chan upgrades FedEx (NYSE:FDX) from Hold to Buy and raises the price target from $171 to $222. FDX